Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dihydroartemisinin enhances gefitinib cytotoxicity against lung adenocarcinoma cells by inducing ROS ‐dependent apoptosis and ferroptosis
Xiangyu Lai, Yumei Shi, M Zhou
The Kaohsiung Journal of Medical Sciences (2023) Vol. 39, Iss. 7, pp. 699-709
Open Access | Times Cited: 13

Showing 13 citing articles:

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 133
Blockage of Autophagy for Cancer Therapy: A Comprehensive Review
Ahmed Hassan, Yuxin Zhao, Xiuping Chen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7459-7459
Open Access | Times Cited: 11
Natural products targeting autophagy and apoptosis in NSCLC: a novel therapeutic strategy
Peiyi Qin, Qingchen Li, Qi Zu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer
Yumin Wang, Jing Hu, Joshua S. Fleishman, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer
Wei Lin, Xiaojun Wang, Mingxin Diao, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies
Yunbin Li, Xiaosong Li, Jian Li
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds
Qiuran Liang, Yuehui Wang, Yili Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
[Role of Ferroptosis in Non-small Cell Lung Cancer and Progress 
of Traditional Chinese Medicine Intervention].
Xiaoqi Guo, Tianqi Wang, Jinchan Xia, et al.
PubMed (2024) Vol. 27, Iss. 3, pp. 216-230
Closed Access | Times Cited: 2
Targeting ferroptosis regulators in lung cancer: Exploring natural products
Yuhao Wang, Cheng Shenghua, Chen Jueying, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e33934-e33934
Open Access | Times Cited: 2
Natural products targeting ferroptosis pathways in cancer therapy (Review)
Na Xin, Lin Li, Dongmei Liu, et al.
Oncology Reports (2024) Vol. 52, Iss. 3
Open Access | Times Cited: 1
Dihydroartemisinin restores the immunogenicity and enhances the anticancer immunosurveillance of cisplatin by activating the PERK/eIF2α pathway
Yumei Li, Pei Ma, Jingxia Li, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
FTO/m6A mediates miR-138-5p maturation and regulates gefitinib resistance of lung adenocarcinoma cells by miR-138-5p/LCN2 axis
Dongxiao Ding, Wenjun Shang, Ke Shi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Ferroptosis-inducing nanocomposite hydrogels: A multimodal platform for enhanced cancer therapeutics
Shanhe Li, Yuqing Qian, Xuan Zhang, et al.
Chemical Engineering Journal (2024) Vol. 500, pp. 157451-157451
Closed Access | Times Cited: 1
Page 1

Scroll to top